SMS Pharmaceuticals Ltd

NSE: SMSPHARMA · BSE: 532815 · Pharmaceuticals & Biotechnology · 25 announcements

Share price: ₹469.55
Market cap: ₹4,163 Cr
Revenue (annual): ₹886.9 Cr
Net profit (annual): ₹102.0 Cr
P/E (TTM): 40.6×Sector 47.4×
Promoter holding: 68.07%+0.00% QoQ
FII holding: 0.65%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

30 Apr 2026 15:49 IST BSE

SMS Pharmaceuticals Debt & Borrowing

SMS Pharmaceuticals Limited confirmed it does not fall under the 'Large Corporate' category as of March 31, 2026, per SEBI framework. Consequently, provisions for initial and annual disclosures regarding fund raising through debt securities are not applicable to the company.

Read the filing ↗